Singapore markets open in 6 hours 4 minutes

TRACON Pharmaceuticals, Inc. (TCON)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.8100+0.0500 (+2.84%)
As of 02:31PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 4.00M
Enterprise value -4.32M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.24
Price/book (mrq)N/A
Enterprise value/revenue -0.36
Enterprise value/EBITDA -1.15

Trading information

Stock price history

Beta (5Y monthly) 1.27
52-week change 3-86.79%
S&P500 52-week change 325.59%
52-week high 314.7400
52-week low 31.5900
50-day moving average 34.5841
200-day moving average 34.2126

Share statistics

Avg vol (3-month) 3259.22k
Avg vol (10-day) 3168.87k
Shares outstanding 52.28M
Implied shares outstanding 62.28M
Float 82.08M
% held by insiders 12.59%
% held by institutions 111.94%
Shares short (15 Apr 2024) 424.41k
Short ratio (15 Apr 2024) 40.09
Short % of float (15 Apr 2024) 41.08%
Short % of shares outstanding (15 Apr 2024) 41.07%
Shares short (prior month 15 Mar 2024) 494.86k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 308 Nov 2019
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 310 Apr 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -29.79%
Operating margin (ttm)13.37%

Management effectiveness

Return on assets (ttm)-29.16%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)12.04M
Revenue per share (ttm)7.36
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -6.88M
Net income avi to common (ttm)-3.59M
Diluted EPS (ttm)-2.2000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.56M
Total cash per share (mrq)3.76
Total debt (mrq)968k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.89
Book value per share (mrq)-0.37

Cash flow statement

Operating cash flow (ttm)3.68M
Levered free cash flow (ttm)-1.72M